Real|world treatment patterns and survival outcomes for patients ...

Real-world treatment patterns and survival outcomes for patients ...

This TTR analysis describes the clinical reality surrounding the initial management and survival outcomes for stage III NSCLC in Spain and ...

Real-World Treatment Patterns and Survival Outcomes for Patients ...

Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, with ~40-50% of patients diagnosed with ...

Real-world treatment patterns and survival outcomes for patients ...

Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.

Real-world survival outcomes and treatment patterns in patients (pts ...

Our study provides real-world data on treatment patterns and reports poor prognosis with pts reaching a mOS of ∼13 months.

Real-World Treatment Patterns and Survival Outcomes for Patients ...

In this study, we explored treatment patterns and outcomes for patients with non-metastatic NSCLC in Sweden prior to the availability of these treatments.

Real-world treatment patterns and outcomes in patients with HR+ ...

This real-world study describes treatment patterns and outcomes in patients treated with chemotherapy in the United States before approval of antibody–drug ...

Real-world treatment patterns, survival outcomes, and health care ...

The study presented here used real-world data to provide information about patient characteristics, treatment patterns, survival, and HCRU in ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

In 561 patients with 1 prior LOT at inclusion, the cumulative attrition rate from LOT 2 to 5 was 85%, which included 25% patients who died and ...

Real-world treatment patterns and outcomes of patients with ...

Data to guide treatment selection in metastatic nonsquamous (mNSq) non-small cell lung cancer (NSCLC) after progression on current ...

Treatment Patterns and Survival Outcomes Among Androgen ...

OS was defined as the time from the index date until death. Patients who remained alive were censored at the date that they were last observed in the data. Real ...

Real-world treatment patterns, survival outcomes, and health care ...

Background: Real-world evidence on la/mUC management in Europe is limited. This study describes patient (pt) characteristics, treatment patterns ...

Recent real-world treatment patterns and outcomes in US patients ...

Real-world data describing treatment patterns in relapsed/refractory multiple myeloma are limited. Evaluation of new treatments on patient ...

Real-world evidence of treatment patterns and survival of metastatic ...

Almost half of mGC patients remained without systemic therapy. Patients who received disease-specific therapy were more likely to be male, young ...

Real-world treatment patterns and clinical outcomes among patients ...

This large-scale, US-based study characterized real-world treatment patterns and clinical outcomes in patients with advanced or metastatic urothelial carcinoma ...

Recent treatment patterns and real-world survival following first-line ...

Lower OS rates in real-world cohorts in general are not unexpected given real-world cohorts are generally sicker than the patients enrolled in ...

Real-world treatment patterns and overall survival among men with ...

Median survival from diagnosis for all patients was 25.6 months. These data highlight the dramatic undertreatment that occurs for mCRPC patients ...

Real-world treatment patterns and survival outcomes for advanced ...

OS, duration of therapy, and time to subsequent LoT or death were estimated using the Kaplan–Meier method. Patients in whom the outcomes of ...

Real-world treatment patterns and survival outcomes for treated ...

Among the full cohort, patients who received fol or gem/cis in 1L had the best mOS. After each line of therapy, there is a steep decrease in the ...

Real-World Treatment Patterns and Survival Outcomes for Patients ...

Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden: A Nationwide Registry Analysis from ...

Study to Describe the Real-world Treatment Patterns and ...

This multicountry, multicenter, retrospective, non-interventional study involving patients diagnosed with HER2-positive unresectable or metastatic breast ...